Heghine Khachatryan: How Well Do We Recognize Anti-PF4 Disorders?
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared Shinya Goto‘s post on LinkedIn:
“An outstanding and highly relevant review on platelet-activating anti-PF4 disorders.
For practicing clinicians, these immune-mediated thrombotic syndromes are no longer rare academic entities.
HIT, autoimmune HIT, spontaneous HIT, VITT, and VITT-like disorders are increasingly recognized across diverse clinical settings, making early suspicion, timely laboratory diagnosis, and prompt initiation of appropriate therapy essential for improving patient outcomes.
This review provides an excellent synthesis of current concepts in the pathophysiology, diagnosis, and management of anti-PF4 disorders and will undoubtedly become an important reference for physicians involved in thrombosis, hemostasis, intensive care, hematology, and vascular medicine.
Congratulations to the authors on this outstanding contribution to the field.”
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article by Theodore E. Warkentin et al., published in NEJM, adding:
“Very good review regarding Platelet-Activating Anti–Platelet Factor 4 Disorders including HIT!”
Title: Very good review regarding Platelet-Activating Anti–Platelet Factor 4 Disorders including HIT!
Authors: Theodore E. Warkentin, Andreas Greinacher
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question